Subscribe to RSS
DOI: 10.1055/s-0038-1627350
Alternativmedizin und Multiple Sklerose
Alternative medicine and multiple sclerosisPublication History
Eingegangen am:
06 October 2008
angenommen am:
06 October 2008
Publication Date:
20 January 2018 (online)
Zusammenfassung
Trotz eines zweifellosen Fortschritts in der Behandlung der Multiplen Sklerose (MS) in den letzten Jahren bleibt die MS weiterhin eine chronische, unheilbare Erkrankung mit erheblichen Auswirkungen auf das alltägliche Leben des Betroffenen. Deshalb erscheint der weitverbreitete Gebrauch alternativer Heilmethoden bei MS-Patienten verständlich. Dies wurde von der Forschung bis vor Kurzem wenig gewürdigt. Das Ziel, Nebenwirkungen der konventionellen Medikamente zu vermeiden, aber auch die größere emotionale Unterstützung, die viele alternative Heiler bieten, wie auch die Möglichkeit, sich aktiv an Behandlungen zu beteiligen, sind wesentliche Motivationen, die zur Alternativmedizin führen. Es wird ein weites Spektrum verschiedener alternativer Behandlungsformen angeboten, darunter überwiegend wenig riskante Verfahren wie Diät, Nahrungsergänzungsmittel vorwiegend durch ungesättigte Fettsäuren und Vitamine, Pflanzenmedizin, Homöopathie oder physiomentale Therapien. Allerdings werden auch einige Behandlungen mit potenziell schweren bis lebensbedrohlichen Risiken angeboten. Für den größten Teil der alternativen Behandlungsverfahren existieren keine Evidenzdaten aus kontrollierten Studien. Zu wenigen Verfahren wurden kontrollierte Studien durchgeführt, die jedoch weitgehend keine signifikanten Effekte zeigen konnten.
Summary
Despite of an undoubtable progress in the treatment of multiple sclerosis (MS) that has been made for the last years, MS still remains to be a chronic incurable disease with a high impact on the patient‘s daily life. Therefore, it seems reasonable that there is a widespread use of alternative methods among patients with MS. This has been disregarded in research until lately. The aim of avoiding side effects caused by the conventional medication, but also a higher emotional support provided by the alternative therapist, and the option of active self engagement seem to be crucial motivations for the utilization of alternative medicine (AM). A wide range of different alternative therapies is available for MS including mainly low risk methods such as dietary modification, nutritional supplementation predominantly with essential fatty acids and vitamins, herbal medicine, homeopathy and mind-body therapies. However, some of the offered alternative approaches may cause severe and even fatal side effects. For the greatest part of the alternative therapies no data arising from controlled trials concerning the efficacy in MS currently exist. For a few methods controlled trials mostly have failed to show a significant effect.
-
Literatur
- 1 Aminzadeh KK, Etminan M. Dental amalgam and multiple sclerosis: a systematic review and metaanalysis. J Public Health Dent 2007; 67 (Suppl. 01) 64-66.
- 2 Apel A. et al. Frequency of current utilisation of complementary and alternative medicine by patients with multiple sclerosis. J Neurol 2006; 253 (Suppl. 10) 1331-1336.
- 3 Campbell DG. et al. Complementary and alternative medicine use in veterans with multiple sclerosis: Prevalence and demographic associations. J Rehabil Res Dev 2006; 43 (Suppl. 01) 99-110.
- 4 Carlson MJ, Krahn G. Use of complementary and alternative medicine practitioners by people with physical disabilities: estimates from a National US Survey. Disabil Rehabil 2006; 28 (Suppl. 08) 505-513.
- 5 Fryze W. et al. Alternative methods of treatment used by multiple sclerosis patients in Poland. Neurol Neurochir Pol 2006; 40 (Suppl. 05) 386-390.
- 6 Goldberg P, Fleming MC, Picard EH. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypotheses 1986; 21: 193-200.
- 7 Harbige LS. Dietary n-6 and n-3 fatty acids in immunity and autoimmune disease. Proc Nutr Soc 1998; 57: 555-562.
- 8 Häußermann D. Allensbach-Studie. Wachsendes Vertrauen in Naturheilmittel Dtsch Arztebl 1997; 94 (Suppl. 39) A2466.
- 9 Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357 (Suppl. 03) 266-281.
- 10 http://de.wikipedia.org/wiki/Alternativmedizin.
- 11 Lauer K. Diet and multiple sclerosis. Neurology 1997; 49: 55-61.
- 12 Munger KL. et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296: 2832-2838.
- 13 Page SA. et al. The use of complementary and alternative therapies by people with multiple sclerosis. Chronic Dis Can 2003; 24 2–3 75-79.
- 14 Prochazkova J. et al. The beneficial effect of amalgam replacement on health in patients with autoimmunity. Neuro Endocrinol Lett 2004; 25 (Suppl. 03) 211-218.
- 15 Rog DJ. et al. Randomized, controlled trial of cannabis- based medicine in central pain in multiple sclerosis. Neurology 2005; 65 (Suppl. 06) 812-819.
- 16 Schwarz S. et al. Complementary and alternative medicine for multiple sclerosis. Mult Scler 2008; 14 (Suppl. 08) 1113-1119.
- 17 Schwarz S. et al. Unkonventionelle Therapien der multiplen Sklerose: Nutzen unklar. Dtsch Ärzteblatt 2005; 102 (Suppl. 30) A2102-2107.
- 18 Schwarz S, Leweling H, Meinck HM. Alternative und komplementäre Therapien der Multiplen Sklerose. Fortschr Neurol Psychiatr 2005; 73: 451-462.
- 19 Schwarz S, Leweling H. Diät und Multiple Sklerose. Nervenarzt 2005; 76 (Suppl. 02) 131-142.
- 20 Shinto L. et al. Demographic and health-related factors associated with complementary and alternative medicine (CAM) use in multiple sclerosis. Mult Scler 2006; 12 (Suppl. 01) 94-100.
- 21 Soilu-Hänninen M. et al. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis. J Neurol Neurosurg Psychiatry 2008; 79 (Suppl. 02) 152-157.
- 22 Swank RL, Dugan BB. Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet 1990; 336 8706 37-39.
- 23 Wesselius T. et al. A randomized crossover study of bee sting therapy for multiple sclerosis. Neurology 2005; 65 (Suppl. 11) 1764-1768.
- 24 Wingerchuk DM. et al. A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsingremitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2005; 76 (Suppl. 09) 1294-1296.
- 25 Winterholler M, Erbguth F, Neundörfer B. Gebrauch von Alternativmedizin durch Multiple Sklerose Patienten — Patientencharakteristiken und Gebrauchsmuster. Fortschr Neurol Psychiatr 1997; 65 (Suppl. 12) 555-561.
- 26 Zajicek J. et al. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet 2003; 362 9395 1517-1526.